Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches

While the majority of breast cancers are diagnosed at a curable stage, approximately 20% of women will experience recurrence at a distant site during their lifetime. These metastatic recurrences are incurable with current therapeutic approaches. Over the past decade, the biologic mechanisms underlyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cescon, David W., Kalinsky, Kevin, Parsons, Heather A., Smith, Karen Lisa, Spears, Patricia A., Thomas, Alexandra, Zhao, Fengmin, DeMichele, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867255/
https://www.ncbi.nlm.nih.gov/pubmed/35223447
http://dx.doi.org/10.3389/fonc.2021.667397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867255/
https://www.ncbi.nlm.nih.gov/pubmed/35223447
http://dx.doi.org/10.3389/fonc.2021.667397

Ejemplares similares